PDL BioPharma CEO Dominique Monnet's 2019 pay jumps 168% to $6.7M

PDL BioPharma reports 2019 executive compensation

By ExecPay News

Published: July 7, 2020

PDL BioPharma reported fiscal year 2019 executive compensation information on July 7, 2020.
In 2019, five executives at PDL BioPharma received on average a compensation package of $2.8M, a 19% increase compared to previous year.
Average pay of disclosed executives at PDL BioPharma
Dominique Monnet, Chief Executive Officer, received $6.7M in total, which increased by 168% compared to 2018. 57.04% of Monnet's compensation, or $3.8M, was in option awards. Monnet also received $508K in non-equity incentive plan, $635K in salary, $1.7M in stock awards, as well as $58K in other compensation.
Peter Garcia, Chief Financial Officer, received a compensation package of $2.6M, which increased by 22% compared to previous year. 49.91% of the compensation package, or $1.3M, was in other compensation.
Christopher Stone, General Counsel, earned $2.5M in 2019, a 15% increase compared to previous year.
Jill Jene, Vice President, Business Development, received $1.2M in 2019, which increases by 61% compared to 2018.
Edward Imbrogno, Chief Financial Officer, earned $814.1K in 2019.

Related executives

Dominique Monnet

PDL BioPharma

Chief Executive Officer

Edward Imbrogno

PDL BioPharma

Chief Financial Officer

Christopher Stone

PDL BioPharma

General Counsel

Peter Garcia

PDL BioPharma

Chief Financial Officer

Jill Jene

PDL BioPharma

Vice President, Business Development

You may also like

Source: SEC filing on July 7, 2020.